Gene therapy trial in Alzheimer's disease planned

With all the bad news coming out on efforts to find a cure for Alzheimer’s disease, there was a refreshing, albeit optimistic, announcement on a novel approach.

The USA’s Libella Gene Therapeutics has said it will conduct an outside the USA clinical trial in Cartagena, Colombia, using gene therapy to reverse age-related diseases, starting with Alzheimer's.

Unlike traditional drugs, which tend to be taken for months or years at a time, gene therapy interventions are intended to be one-off treatments that tackle a disease at its source, repairing faulty DNA and allowing the body to fix itself.